Stevia — Benefits Deep Dive

Stevia is the rare herb whose most important benefit is something it does not do. Purified steviol glycosides are hundreds of times sweeter than sugar and are not absorbed in the small intestine, so they deliver sweetness without calories and without a glucose response. Everything genuinely established about stevia's health effects flows from that single fact, and from what the sweetness replaces.

The rest of the marketing is weaker than it sounds. Stevia does not lower hemoglobin A1c (HbA1c). It is not a weight-loss agent, and in 2023 the World Health Organization advised against using non-sugar sweeteners for weight control at all. The blood-pressure claim rests mainly on two trials in Chinese patients using drug-level doses; a 2015 pooled analysis of nine trials found a small fall in diastolic pressure, with large inconsistency between trials. And the alarming cardiovascular headline that broke in 2023 belongs to erythritol — the bulking agent that fills most retail stevia packets — and not to stevia itself, a distinction almost every news story got wrong.

These four deep dives take each claim in turn and label the evidence honestly: randomized clinical trial, preliminary (animal or in vitro), or traditional use only. Where the evidence is weak, they say so at the top rather than at the bottom.

Before Anything Else: Three Different Products

Nothing on any of these pages can be read correctly without separating them, because the evidence does not transfer between them.

  1. Whole stevia leaf — the traditional Guaraní ka'a he'ê, used for centuries to sweeten yerba mate and bitter medicinal infusions. It is not an approved sweetener in the United States or the European Union; the U.S. Food and Drug Administration (FDA) maintains an import alert on leaf and crude extract for food use. In the US it is legally sold only as a dietary supplement or herbal tea. Almost no clinical trial has used it.
  2. Purified steviol glycosides — rebaudioside A, stevioside, and increasingly rebaudiosides D and M, refined to not less than 95% total glycosides. This is the approved sweetener: generally recognized as safe-notified in the US since 2008 and authorised in the EU as additive E 960. The Acceptable Daily Intake set by the Joint FAO/WHO Expert Committee on Food Additives is 4 mg per kg of body weight per day, expressed as steviol equivalents. Virtually every trial cited on this site tested this form.
  3. Retail tabletop "stevia" — the packets and spoonable tubs. By weight these are overwhelmingly a bulking agent, usually erythritol, sometimes dextrose or maltodextrin, carrying a trace of rebaudioside. A rebaudioside is 200 to 400 times sweeter than sugar, so a teaspoon-equivalent is a few milligrams and something has to fill the spoon. Most "is stevia safe?" questions are really questions about the bulking agent.

Deep-Dive Articles

Table of Contents

  1. Before Anything Else: Three Different Products
  2. Deep-Dive Articles
  3. Key Research: Blood Glucose and Insulin
  4. Key Research: Weight, Appetite and the World Health Organization Guideline
  5. Key Research: Blood Pressure
  6. Key Research: Microbiome and Metabolic Fate
  7. Key Research: Safety, Allergenicity and Erythritol
  8. External Resources
  9. Connections
  10. Featured Videos

Key Research: Blood Glucose and Insulin

Papers checked against their PubMed records link to them by PMID; the others are PubMed search links, so that you resolve each paper from its stated title, journal and year.

  1. Maki KC et al. Chronic consumption of rebaudioside A, a steviol glycoside, in men and women with type 2 diabetes mellitus. Food and Chemical Toxicology, 2008. Adults with type 2 diabetes (60 on rebaudioside A, 62 on placebo), sixteen weeks at 1,000 mg/day; HbA1c changes did not differ (+0.11% vs +0.09%, p=0.355), nor did fasting glucose or insulin, and records of low-blood-sugar (hypoglycaemic) episodes showed no excess over placebo. — PubMed PMID: 18555575
  2. Barriocanal LA et al. Apparent lack of pharmacological effect of steviol glycosides used as sweeteners in humans. Regulatory Toxicology and Pharmacology, 2008. Three months in type 1 diabetes, type 2 diabetes and healthy controls. — PubMed PMID: 18397817
  3. Gregersen S et al. Antihyperglycemic effects of stevioside in type 2 diabetic subjects. Metabolism, 2004. The 12-participant outlier: in a single test meal, 1 gram of stevioside cut the rise in blood glucose (area under the curve) by 18% compared with 1 gram of maize starch (P=.013). — PubMed PMID: 14681845
  4. Nichol AD, Holle MJ, An R. Glycemic impact of non-nutritive sweeteners: a systematic review and meta-analysis of randomized controlled trials. European Journal of Clinical Nutrition, 2018. — Find on PubMed
  5. Tey SL et al. Effects of aspartame-, monk fruit-, stevia- and sucrose-sweetened beverages on postprandial glucose, insulin and energy intake. International Journal of Obesity, 2017. — Find on PubMed
  6. Zare M et al. Effect of stevia on blood glucose and HbA1C: a meta-analysis. Diabetes & Metabolic Syndrome, 2024. 26 studies, 1,439 participants: stevia was linked to a small fall in blood glucose (weighted mean difference −3.84, 95% CI −7.15 to −0.53; low certainty), especially in people with a higher body mass index, diabetes or high blood pressure; the dose-response analysis showed a fall at 3,342 mg/day or more. No significant effect on insulin or HbA1c. — PubMed PMID: 39098209

Key Research: Weight, Appetite and the World Health Organization Guideline

  1. World Health Organization. Use of non-sugar sweeteners: WHO guideline. 2023. A conditional recommendation, graded on low-certainty evidence, advising against non-sugar sweeteners for weight control. — Read at WHO
  2. Rios-Leyvraz M, Montez J. Health effects of the use of non-sugar sweeteners: a systematic review and meta-analysis. WHO, 2022. The review underlying the guideline. — Find on PubMed
  3. Miller PE, Perez V. Low-calorie sweeteners and body weight and composition: a meta-analysis of randomized controlled trials and prospective cohort studies. American Journal of Clinical Nutrition, 2014. Trials say down, cohorts say up — the central tension. — Find on PubMed
  4. Rogers PJ et al. Does low-energy sweetener consumption affect energy intake and body weight? A systematic review, including meta-analyses, of the evidence from human and animal studies. International Journal of Obesity, 2016. — Find on PubMed
  5. McGlynn ND et al. Association of low- and no-calorie sweetened beverages as a replacement for sugar-sweetened beverages with body weight and cardiometabolic risk. JAMA Network Open, 2022. — Find on PubMed
  6. Stamataki NS et al. Stevia beverage consumption prior to lunch reduces appetite and total energy intake without affecting glycemia or attentional bias to food cues. The Journal of Nutrition, 2020. — Find on PubMed

Key Research: Blood Pressure

  1. Chan P et al. A double-blind placebo-controlled study of the effectiveness and tolerability of oral stevioside in human hypertension. British Journal of Clinical Pharmacology, 2000. 106 Chinese adults with high blood pressure, 250 mg three times a day (750 mg/day) or placebo for one year; positive. After 3 months, blood pressure in the stevioside group fell from 166.0/104.7 to 152.6/90.3 mmHg, and the effect persisted for the whole year. — PubMed PMID: 10971305
  2. Hsieh MH et al. Efficacy and tolerability of oral stevioside in patients with mild essential hypertension: a two-year, randomized, placebo-controlled study. Clinical Therapeutics, 2003. 174 Chinese adults with mild high blood pressure, 500 mg three times a day (1,500 mg/day) or placebo for two years; positive. Systolic pressure fell from 150 to 140 mmHg and diastolic from 95 to 89 mmHg, significant against placebo; after two years, thickened heart muscle (left ventricular hypertrophy) was found in 6 of 52 patients on stevioside versus 17 of 50 on placebo. — PubMed PMID: 14693305
  3. Ferri LA et al. Investigation of the antihypertensive effect of oral crude stevioside in patients with mild essential hypertension. Phytotherapy Research, 2006. Independent replication attempt in Brazil; negative. Crude stevioside was raised in steps up to 15.0 mg/kg/day; blood pressure fell, but a similar fall occurred in the placebo group. — PubMed PMID: 16775813
  4. Maki KC et al. The hemodynamic effects of rebaudioside A in healthy adults with normal and low-normal blood pressure. Food and Chemical Toxicology, 2008. Designed around the question; negative. — PubMed PMID: 18555574
  5. Onakpoya IJ, Heneghan CJ. Effect of the natural sweetener, steviol glycoside, on cardiovascular risk factors: a systematic review and meta-analysis of randomised clinical trials. European Journal of Preventive Cardiology, 2015. Nine trials, 756 participants: no significant difference in systolic pressure (mean difference −2.98 mm Hg, 95% CI −6.23 to 0.27), but significant reductions in diastolic pressure and fasting blood glucose. The authors concluded that stevioside may produce reductions in blood pressure and fasting blood glucose, that the effects are small and the substantial inconsistency between trials (heterogeneity) limits the robustness of any conclusions, and that rebaudioside A does not appear to have significant effects. — PubMed PMID: 25412840

Key Research: Microbiome and Metabolic Fate

  1. Suez J et al. Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance. Cell, 2022. All four sweeteners shifted the microbiome; only saccharin and sucralose impaired glycaemic responses. — PubMed PMID: 35987213
  2. Gardana C et al. Metabolism of stevioside and rebaudioside A from Stevia rebaudiana extracts by human microflora. Journal of Agricultural and Food Chemistry, 2003. The Bacteroides hydrolysis pathway. — Find on PubMed
  3. Purkayastha S, Kwok D. Metabolic fate in adult and pediatric population of steviol glycosides produced from stevia leaf and bioconversion. Regulatory Toxicology and Pharmacology, 2020. — Find on PubMed
  4. Ruiz-Ojeda FJ et al. Effects of sweeteners on the gut microbiota: a review of experimental studies and clinical trials. Advances in Nutrition, 2019. — Find on PubMed
  5. Kasti AN et al. The effects of stevia consumption on gut bacteria: friend or foe? Microorganisms, 2022. — Find on PubMed
  6. Kwok D et al. Comparison of a daily steviol glycoside beverage compared with a sucrose beverage for four weeks on gut microbiome in healthy adults. The Journal of Nutrition, 2024. Randomized, double-blind: 59 healthy adults drank a beverage sweetened with stevia at 25% of the acceptable daily intake, or with 30 g of sugar (sucrose), every day for four weeks. There were no significant differences in gut bacteria at any level or in fecal short-chain fatty acids; body mass index rose 0.3 kg/m² more in the sugar group. The comparison here was sugar, whereas the 2022 Cell trial compared two weeks of sweetener sachets with glucose or no supplement in 120 adults. — PubMed PMID: 38408729

Key Research: Safety, Allergenicity and Erythritol

  1. Witkowski M et al. The artificial sweetener erythritol and cardiovascular event risk. Nature Medicine, 2023. About the bulking agent, not about stevia. — Find on PubMed
  2. Mazi TA, Stanhope KL. Erythritol: an in-depth discussion of its potential to be a beneficial dietary component. Nutrients, 2023. The counter-argument, including endogenous production. — Find on PubMed
  3. Witkowski M et al. Ingestion of the non-nutritive sweetener erythritol, but not glucose, enhances platelet reactivity and thrombosis potential in healthy volunteers — brief report. Arteriosclerosis, Thrombosis, and Vascular Biology, 2024. Ten healthy volunteers per group: 30 g of erythritol raised blood erythritol more than 1,000-fold and increased platelet clumping (aggregation) responses in every subject; 30 g of glucose did not have this effect. About the bulking agent, not about stevia. — PubMed PMID: 39114916
  4. EFSA Panel on Food Additives and Flavourings (FAF), Younes M et al. Re-evaluation of erythritol (E 968) as a food additive. EFSA Journal, December 2023. The European Food Safety Authority set an acceptable daily intake for erythritol of 0.5 g per kg of body weight per day, based on its potential to cause diarrhoea. Estimated intakes, highest in children and adolescents, were above that level, indicating that people with high intake may be at risk of adverse effects; the Panel considered its exposure estimates an overestimation. — PubMed PMID: 38125972
  5. Urban JD, Carakostas MC, Taylor SL. Steviol glycoside safety: are highly purified steviol glycoside sweeteners food allergens? Food and Chemical Toxicology, 2015. — Find on PubMed
  6. Urban JD et al. Steviol glycoside safety: is the genotoxicity database sufficient? Food and Chemical Toxicology, 2013. — Find on PubMed
  7. Toews I et al. Association between intake of non-sugar sweeteners and health outcomes: systematic review and meta-analyses of randomised and non-randomised controlled trials and observational studies. BMJ, 2019. — Find on PubMed
  8. Samuel P et al. Stevia leaf to stevia sweetener: exploring its science, benefits, and future potential. The Journal of Nutrition, 2018. — Find on PubMed

External Resources

Connections


Back to Table of Contents